Meiling Zhang Selected Research

Pharmaceutical Preparations

10/2022	Integrative analysis of network pharmacology and proteomics to identify key targets of Tuomin-Zhiti-Decoction for allergic rhinitis.
1/2022	Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
12/2021	Transcriptional regulation of telomeric repeat-containing RNA by acridine derivatives.
10/2021	A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
4/2021	Green Phellodendri Chinensis Cortex-based carbon dots for ameliorating imiquimod-induced psoriasis-like inflammation in mice.
1/2021	Gastroprotective effects of Nelumbinis Rhizomatis Nodus-derived carbon dots on ethanol-induced gastric ulcers in rats.
1/2020	A Meta-Analysis of Abnormal Glucose Metabolism in First-Episode Drug-Naive Schizophrenia.
1/2019	Insights Into the Resistance Mechanisms of Inhibitors to FLT3 F691L Mutation via an Integrated Computational Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meiling Zhang Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 01/2013
8	Inflammation (Inflammations) 07/2022 - 10/2019
6	Poisoning 01/2016 - 01/2014
5	Infections 03/2021 - 01/2018
5	Wounds and Injuries (Trauma) 01/2019 - 09/2011
4	Liver Diseases (Liver Disease) 08/2022 - 01/2021
4	COVID-19 02/2022 - 01/2021
4	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2018
4	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2016
4	Stomach Neoplasms (Stomach Cancer) 01/2018 - 03/2013
3	Insulin Resistance 05/2021 - 10/2016
3	Stomach Ulcer (Gastric Ulcer) 03/2021 - 01/2021
3	Fibrosis (Cirrhosis) 10/2019 - 07/2011
2	Tuberculosis (Tuberculoses) 05/2022 - 10/2021
2	Drug-Related Side Effects and Adverse Reactions 05/2022 - 10/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
2	Brain Ischemia (Cerebral Ischemia) 08/2021 - 02/2019
2	Stroke (Strokes) 08/2021 - 02/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2021 - 02/2019
2	Lymphoma (Lymphomas) 01/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2020
2	Necrosis 01/2021 - 12/2020
2	Adenocarcinoma of Lung 01/2020 - 01/2013
2	Pain (Aches) 01/2020 - 01/2015
2	Diabetic Cardiomyopathies 01/2020 - 10/2019
2	Body Weight (Weight, Body) 01/2020 - 01/2018
2	Gouty Arthritis 11/2019 - 11/2019
2	Hemorrhage 01/2019 - 01/2018
2	Carcinogenesis 01/2019 - 01/2018
2	Asthma (Bronchial Asthma) 01/2015 - 10/2013
1	Hypersensitivity (Allergy) 10/2022
1	Allergic Rhinitis 10/2022
1	Hepatitis A (Hepatitis, Infectious) 05/2022
1	Hepatitis 05/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Malaria 01/2022
1	Schmid-Fraccaro syndrome 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022

Drug/Important Bio-Agent (IBA)

12	CarbonIBA 12/2021 - 01/2018
8	Pharmaceutical PreparationsIBA 10/2022 - 01/2019
6	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2014
6	Long Noncoding RNAIBA 01/2021 - 01/2013
5	Biological ProductsIBA 01/2022 - 11/2019
5	RNA (Ribonucleic Acid)IBA 08/2021 - 02/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2018 - 02/2015
3	Lysine (L-Lysine)FDA Link 01/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 08/2021 - 01/2020
3	CholesterolIBA 05/2021 - 01/2015
3	Insulin (Novolin)FDA Link 05/2021 - 10/2016
3	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2020
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2017
3	AcidsIBA 01/2021 - 01/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2017
3	ParaquatIBA 01/2016 - 01/2015
2	ORALIT (ORS)IBA 08/2022 - 10/2021
2	Evans Blue (Blue, Evans)FDA Link 01/2022 - 08/2021
2	EnzymesIBA 01/2022 - 01/2018
2	ChromatinIBA 01/2022 - 01/2013
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 12/2021 - 05/2021
2	Aspartic Acid (Aspartate)FDA Link 08/2021 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021 - 01/2020
2	LipidsIBA 05/2021 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 05/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2018
2	AntioxidantsIBA 01/2021 - 06/2018
2	InterleukinsIBA 01/2021 - 01/2020
2	CrizotinibIBA 01/2021 - 11/2018
2	acridoneIBA 01/2021 - 01/2020
2	Malondialdehyde (Propanedial)IBA 01/2021 - 05/2015
2	Oxytetracycline (Terramycin)FDA Link 01/2020 - 01/2018
2	VenomsIBA 12/2019 - 01/2019
2	Uric Acid (Urate)IBA 11/2019 - 11/2019
2	Xanthine OxidaseIBA 11/2019 - 11/2019
2	Alanine (L-Alanine)FDA Link 01/2019 - 01/2015
2	Hemostatics (Antihemorrhagics)IBA 01/2019 - 01/2018
2	Histones (Histone)IBA 01/2019 - 01/2018
2	Hormones (Hormone)IBA 10/2016 - 12/2013
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2016 - 01/2015
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2015 - 01/2014
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2015 - 01/2014
2	Urea (Carbamide)FDA LinkGeneric 01/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2014
2	Valine (L-Valine)FDA Link 01/2015 - 01/2014
1	Immunoglobulin E (IgE)IBA 10/2022
1	Folic Acid AntagonistsIBA 07/2022
1	Antitubercular AgentsIBA 05/2022
1	PolyphenolsIBA 02/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	artemisinin (artemisinine)IBA 01/2022
1	CytokinesIBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022

Therapy/Procedure

10	Therapeutics 01/2022 - 10/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2015
2	Immunotherapy 01/2022 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2018 - 01/2015